P

Permira

Global private equity investor

Overview

Permira is a global private equity firm with European roots that raises investment funds to buy and grow companies around the world. It acquires businesses, partners with management to implement strategic and operational improvements, and exits holdings through sales or listings to generate returns for investors. The firm differentiates itself with a long-standing track record, hands-on operational guidance, and a global network across multiple sectors. Its goal is to deliver strong, risk-adjusted returns for institutional investors by building durable, high-performing companies.

Work here?Claim your company

About Permira

Simplify's Rating
Why Permira is rated
B
Rated A on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Venture CapitalFinancial Services

Company Size

201-500

Company Stage

N/A

Total Funding

$7B

Headquarters

London, United Kingdom

Founded

1985

Get referred to Permira

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Sept. 2026 JTC closed, adding a private, acquisition-ready FACTS platform.
  • Aug. 2026 BioCatch sale to Visa delivered Permira’s fifth strategic exit of 2026.
  • Sept. 2026 Cloudnine and Aug. 2026 Third Space show active deployment into growth niches.

What critics are saying

  • Cloudnine still awaits CCI approval; regulators are probing Permira’s pharmaceutical links.
  • Third Space’s £700 million auction risks price inflation and weaker returns.
  • BioCatch’s $2.4 billion sale removes a high-growth cybersecurity asset before 2027 close.

What makes Permira unique

  • Sept. 2026 JTC buyout shows Permira wins founder-led, cash-generative services platforms.
  • Permira combines technology-led operating playbook with global healthcare, services, and consumer reach.
  • BioCatch, FullStory, and McAfee prove durable cybersecurity and software sourcing capability.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$7B

Above

Industry Average

Funded Over

0 Rounds

Company News

Permira
Oct 26th, 2026
Permira appoints Dr John Tang as Senior Adviser.

Permira appoints Dr John Tang as Senior Adviser. We believe the winners will combine deep domain expertise with technology, proprietary data and AI to deliver better outcomes for customers and scale in fundamentally different ways. John brings a rare combination of investment judgement, technical depth and operating experience, and we're delighted to welcome him to the team. Philip Muelder and Daniel Brenhouse Partners and Co-Heads of Services at Permira * AI and technology leader brings more than two decades of experience spanning investing, technology and operational value creation, including senior AI and operating roles at Cerberus Capital Management, Barclays and J.P. Morgan * Appointment strengthens Permira's capabilities to accelerate AI transformation across its Services portfolio and back the next generation of AI-enabled services businesses London and Menlo Park - October 26th - Permira, the global investment firm, today announced the appointment of Dr John Tang as a Senior Adviser to its Services team. Based in London, Dr Tang will work with Permira's Services team and portfolio company leadership to accelerate AI-led transformation and help identify and build the next generation of AI-enabled services businesses. He brings deep expertise across AI, data, product and engineering, and will support the team both in evaluating new opportunities and in working alongside portfolio companies to build and scale AI capabilities. Dr Tang has more than 20 years of experience across AI, data science, technology and investing. Most recently, he led the EMEA Technology Solutions arm at Cerberus Capital Management, where he was responsible for technology and AI strategy across deal sourcing, due diligence and portfolio value creation. Previously, Dr Tang held senior data and AI leadership roles at Barclays and J.P. Morgan. As Chief Data Scientist at Barclays' UK Information Business, he led the commercialisation of data and AI capabilities serving more than 20 million retail customers. Earlier, as Head of EMEA for J.P. Morgan's Big Data & AI group, he helped develop and execute data and AI strategy across the business. Dr Tang began his career as a research scientist at the University of Cambridge and remains active in the technology ecosystem as an adviser, mentor and venture investor. Philip Muelder and Daniel Brenhouse, Partners and Co-Heads of Services at Permira, said: "AI is creating a significant opportunity across the services ecosystem, not only to transform established businesses, but also to build entirely new company categories. We believe the winners will combine deep domain expertise with technology, proprietary data and AI to deliver better outcomes for customers and scale in fundamentally different ways. John brings a rare combination of investment judgement, technical depth and operating experience, and we're delighted to welcome him to the team." Ben Rogers, Global Director of AI Value Creation at Permira, said: "We are already seeing AI move beyond productivity tools to reshape products, workflows and entire service delivery models. The opportunity is increasingly not just to use AI within a services business, but to redesign the business around AI. John has spent his career at the intersection of AI, technology and commercial value creation, and his experience will be hugely valuable as we partner with management teams to turn that opportunity into tangible growth and competitive advantage." Dr John Tang, Senior Adviser at Permira, said: "AI is fundamentally reshaping services companies, blurring the boundaries between people, software and technology and creating a new generation of businesses that can scale and differentiate in entirely new ways. Permira has a strong track record of backing ambitious teams to build category leaders, and I'm looking forward to working with the global Services investing and AI value creation team to help identify and build the next generation of AI-native services businesses."

MarketScreener
Oct 22nd, 2026
London Stock Exchange Group agrees to buy Octus from Permira for $3.5 billion.

London Stock Exchange Group agrees to buy Octus from Permira for $3.5 billion. Published on 10/22/2026 at 02:55 am EDT By Dominic Chopping London Stock Exchange Group said it has agreed to acquire credit intelligence, data and workflow provider Octus from Permira and management for $3.54 billion. The stock-exchange and financial-information company said last week that it was in talks over the deal. "The acquisition will transform LSEG's presence in credit and private markets data, creating a leading proposition in these high-growth areas," it said Thursday. Separately, the company said it has raised its full-year revenue, margin and free cash flow guidance "following the continued strength of our business in Q3." The company now expects to report organic constant currency growth in total income excluding recoveries of at least 8.0%, from 7.0% to 7.5% previously, noting an acceleration of organic growth in its subscription businesses and continued strong growth in its markets division. The earnings before interest, taxes, depreciation and amortization margin this year is now expected to grow by 100 to 120 basis points at constant currency, having previously expected an improvement of around 100 basis points. Equity free cash flow of at least 2.8 billion pounds ($3.75 billion) is expected this year, up from previous guidance of 2.7 billion pounds. Write to Dominic Chopping at [email protected] (END) Dow Jones Newswires 10-22-26 0254ET (C) Dow Jones - 2026

The Middle Market
Oct 13th, 2026
LSEG in Talks to Acquire Permira-Backed Octus for $3.5B

LSEG in talks to acquire permira-backed Octus for $3.5B. London Stock Exchange Group confirmed it is in talks with Permira to acquire Octus for approximately $3.5 billion, according to Reuters. The potential acquisition would expand LSEG's fixed-income data and analytics capabilities and strengthen its private markets offerings. New York-based Octus provides credit market intelligence, specializing in distressed debt and companies experiencing financial difficulties. The company serves banks and institutional investors through a subscription-based platform that combines reporting, financial analysis, legal expertise and technology-driven monitoring of regulatory and court filings. London-based Permira acquired a controlling stake in Octus from Warburg Pincus in 2022 at a valuation of approximately $1.3 billion. The firm has been exploring a sale since last year and has reportedly engaged with multiple potential buyers. Accordion Buys Stride Stride is an AI-powered software engineering firm specializing in production-grade agentic AI systems. To read the entire story, you must be logged in. Fengate Private Equity Acquires Majority Stake in Clinical Research of West Florida The acquisition marks Fengate's second pharma services platform investment. To read the entire story, you must be logged in. Northrim Horizon Purchases Cressy Door and Fireplace Cressy provides installation, repair and maintenance services for overhead doors, pedestrian doors and fireplaces. To read the entire story, you must be logged in. Llama Capital Partners Buys Fabspeed Motorsport in First Platform Investment Fabspeed manufactures exhaust systems, air intake systems and other aftermarket products for luxury and exotic sports vehicles. To read the entire story, you must be logged in.

SecondaryLink
Sep 29th, 2026
SecondaryLink - Permira, TPG strike $450 million secondary investment in Cloudnine

The shares are reportedly being purchased from True North Capital and TPG's own NewQuest secondaries platform, in a deal valuing the Indian hospital chain at $1.3 billion.

WhalesBook Private Limited
Sep 1st, 2026
Permira acquires 25.71% stake in Cloudnine Hospitals at $1.3B valuation

Global private equity firm Permira is acquiring a 25.71% stake in Kids Clinic India, operator of Cloudnine Hospitals, from True North Capital. The deal values the maternity and paediatric chain at ₹11,000 crore. The transaction comes as Cloudnine integrates its recent acquisition of Apollo Cradle and Fertility for ₹1,550 crore, completed in May 2024, which expanded its network to over 55 centres. Existing investors Temasek and TPG NewQuest are expected to retain their stakes. The deal awaits approval from the Competition Commission of India, which is examining potential vertical relationships between Permira's pharmaceutical interests and the hospital chain's services. Permira will acquire the stake through its Luxembourg-based vehicle, NuageLux BidCo, after emerging as lead investor in a competitive process that included TPG Capital.

Recently Posted Jobs

Sign up to get curated job recommendations

Permira is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs